Targeting IL-23, anti-IL-23 therapy can effectively inhibit multiple inflammatory pathways that are critical for driving autoimmune inflammation [21], and IL-23 blockade with neutralizing antibodies or genetic inactivation of the IL-23p19 gene could dramatically protect animals against allergic response [21]. Here, IL23A is linked to inflammation.